DIP
ABBV icon

DT Investment Partners’s AbbVie ABBV Stock Holding History

DT Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29M Hold
25,006
– – 0.47% 37
2026
Q1 		$5.44M Sell
25,006
-3,597
-13% -$798K 0.45% 37
2025
Q4 		$6.54M Hold
28,603
– – 0.54% 34
2025
Q3 		$6.62M Hold
28,603
– – 0.56% 34
2025
Q2 		$5.31M Sell
28,603
-252
-0.9% -$46.8K 0.48% 37
2025
Q1 		$6.05M Hold
28,855
– – 0.58% 31
2024
Q4 		$5.13M Sell
28,855
-2,000
-6% -$368K 0.43% 38
2024
Q3 		$6.09M Buy
30,855
+260
+0.8% +$48.5K 0.49% 34
2024
Q2 		$5.25M Buy
30,595
+2,000
+7% +$331K 0.46% 36
2024
Q1 		$5.21M Hold
28,595
– – 0.53% 31
2023
Q4 		$4.72M Hold
28,595
– – 0.51% 34
2023
Q3 		$4.26M Hold
28,595
– – 0.52% 34
2023
Q2 		$4.25M Hold
28,595
– – 0.48% 35
2023
Q1 		$4.4M Hold
28,595
– – 0.53% 34
2022
Q4 		$4.62M Buy
28,595
+2,000
+8% +$307K 0.61% 33
2022
Q3 		$3.57M Sell
26,595
-998
-4% -$143K 0.58% 32
2022
Q2 		$4.23M Hold
27,593
– – 0.63% 31
2022
Q1 		$4.47M Buy
27,593
+823
+3% +$120K 0.58% 30
2021
Q4 		$3.63M Sell
26,770
-473
-2% -$55.9K 0.47% 34
2021
Q3 		$2.94M Sell
27,243
-1,006
-4% -$115K 0.39% 42
2021
Q2 		$3.18M Hold
28,249
– – 0.44% 38
2021
Q1 		$3.06M Buy
28,249
+1,179
+4% +$126K 0.44% 41
2020
Q4 		$2.9M Hold
27,070
– – 0.46% 36
2020
Q3 		$2.37M Sell
27,070
-582
-2% -$54.8K 0.34% 37
2020
Q2 		$2.71M Hold
27,652
– – 0.34% 32
2020
Q1 		$2.11M Sell
27,652
-996
-3% -$84.8K 0.34% 28
2019
Q4 		$2.54M Buy
+28,648
New +$2.38M 0.23% 70
2019
Q2 		– Sell
-50,197
Closed -$4.04M – 73
2019
Q1 		$4.04M Buy
50,197
+3,024
+6% +$247K 0.57% 25
2018
Q4 		$4.35M Buy
47,173
+439
+0.9% +$38.6K 0.7% 19
2018
Q3 		$4.42M Buy
46,734
+3,113
+7% +$295K 0.63% 23
2018
Q2 		$4.04M Buy
43,621
+742
+2% +$72.5K 0.62% 22
2018
Q1 		$4.06M Sell
42,879
-120
-0.3% -$13.2K 0.63% 19
2017
Q4 		$4.16M Buy
42,999
+1,830
+4% +$172K 0.66% 15
2017
Q3 		$3.66M Buy
41,169
+14,700
+56% +$1.12M 0.61% 16
2017
Q2 		$1.92M Buy
26,469
+3,658
+16% +$246K 0.37% 21
2017
Q1 		$1.49M Buy
22,811
+1,843
+9% +$116K 0.34% 26
2016
Q4 		$1.31M Buy
20,968
+823
+4% +$50.2K 0.33% 22
2016
Q3 		$1.27M Buy
20,145
+849
+4% +$55K 0.33% 21
2016
Q2 		$1.2M Buy
19,296
+2,818
+17% +$172K 0.32% 23
2016
Q1 		$942K Buy
16,478
+7,523
+84% +$419K 0.27% 25
2015
Q4 		$531K Buy
8,955
+568
+7% +$32.7K 0.16% 50
2015
Q3 		$456K Sell
8,387
-3,227
-28% -$210K 0.14% 51
2015
Q2 		$781K Buy
11,614
+5,630
+94% +$368K 0.2% 49
2015
Q1 		$350K Buy
5,984
+197
+3% +$11.9K 0.11% 49
2014
Q4 		$379K Buy
5,787
+279
+5% +$17.6K 0.12% 51
2014
Q3 		$318K Buy
5,508
+389
+8% +$21.6K 0.1% 69
2014
Q2 		$289K Buy
5,119
+922
+22% +$48.4K 0.1% 59
2014
Q1 		$216K Sell
4,197
-1,078
-20% -$54.5K 0.09% 55
2013
Q4 		$279K Buy
+5,275
New +$259K 0.11% 56

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DT Investment Partners's ABBV Position: Q2 2026 in Review

DT Investment Partners held its AbbVie (ABBV) position steady in Q2 2026 at 25,006 shares worth $6.29M. The position accounts for 0.47% of the portfolio, ranked #37.

DT Investment Partners first reported a position in ABBV in Q4 2013 and has held it in 49 quarters since. The position peaked at $6.62M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DT Investment Partners held 25,006 shares of AbbVie worth $6.29M as of Q2 2026.
  • DT Investment Partners left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.47% of DT Investment Partners's portfolio in Q2 2026, its #37 holding.
  • DT Investment Partners first reported a position in AbbVie in Q4 2013 and has held it in 49 quarters since.
  • DT Investment Partners's AbbVie position peaked at $6.62M in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.